{"entity":{"type":"insider","cik":"0001703623","url":"/insider/0001703623","json_url":"/insider/0001703623.json","name":"Carroll David Francis","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":17,"first":"2017-07-05","last":"2023-05-03","span_basis":"filed_date"},"name_variants":[{"name":"Carroll David Francis","source":"filing","n_filings":17,"first_seen":"2017-07-05","last_seen":"2023-05-03"}],"transactions":[{"id":7929378,"accession":"0001410939-23-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001410939-23-000060","line_url":"/filing/0001410939-23-000060#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63500.0,"shares_display":"63,500","price_per_share":37.04,"price_display":"37.04","price_state":"stated","total_value":2352040.0,"total_display":"2,352,040.00","total_whole":"2,352,040","shares_owned_after":68472.0,"shares_owned_after_display":"68,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-03","scope":"insider"},{"id":8589185,"accession":"0001410939-23-000057","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001410939-23-000057","line_url":"/filing/0001410939-23-000057#line-4","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48171.0,"shares_display":"48,171","price_per_share":30.21,"price_display":"30.21","price_state":"stated","total_value":1455245.91,"total_display":"1,455,245.91","total_whole":"1,455,246","shares_owned_after":68472.0,"shares_owned_after_display":"68,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-24","filed_date":"2023-04-25","scope":"insider"},{"id":8589182,"accession":"0001410939-23-000057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001410939-23-000057","line_url":"/filing/0001410939-23-000057#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1829.0,"shares_display":"1,829","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":54870.0,"total_display":"54,870.00","total_whole":"54,870","shares_owned_after":68472.0,"shares_owned_after_display":"68,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-21","filed_date":"2023-04-25","scope":"insider"},{"id":8515697,"accession":"0001410939-23-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001410939-23-000007","line_url":"/filing/0001410939-23-000007#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3602.0,"shares_display":"3,602","price_per_share":20.06,"price_display":"20.06","price_state":"stated","total_value":72256.12,"total_display":"72,256.12","total_whole":"72,256","shares_owned_after":68472.0,"shares_owned_after_display":"68,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-04","scope":"insider"},{"id":6448456,"accession":"0001410939-22-000136","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001410939-22-000136","line_url":"/filing/0001410939-22-000136#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5671.0,"shares_display":"5,671","price_per_share":21.51,"price_display":"21.51","price_state":"stated","total_value":121983.21,"total_display":"121,983.21","total_whole":"121,983","shares_owned_after":63324.0,"shares_owned_after_display":"63,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-20","scope":"insider"},{"id":6221695,"accession":"0001410939-22-000127","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001410939-22-000127","line_url":"/filing/0001410939-22-000127#line-5","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4932.0,"shares_display":"4,932","price_per_share":21.73,"price_display":"21.73","price_state":"stated","total_value":107172.36,"total_display":"107,172.36","total_whole":"107,172","shares_owned_after":54620.0,"shares_owned_after_display":"54,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-13","scope":"insider"},{"id":6221693,"accession":"0001410939-22-000127","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001410939-22-000127","line_url":"/filing/0001410939-22-000127","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3946.0,"shares_display":"3,946","price_per_share":20.89040800810948,"price_display":"20.89","price_state":"stated","total_value":82433.55,"total_display":"82,433.55","total_whole":"82,434","shares_owned_after":48593.0,"shares_owned_after_display":"48,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-13","scope":"insider","n_lines":2},{"id":6339122,"accession":"0001410939-22-000046","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001410939-22-000046","line_url":"/filing/0001410939-22-000046#line-6","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4684.0,"shares_display":"4,684","price_per_share":19.01,"price_display":"19.01","price_state":"stated","total_value":89042.84,"total_display":"89,042.84","total_whole":"89,043","shares_owned_after":40166.0,"shares_owned_after_display":"40,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-05","filed_date":"2022-04-05","scope":"insider"},{"id":6339115,"accession":"0001410939-22-000046","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001410939-22-000046","line_url":"/filing/0001410939-22-000046","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40941.0,"shares_display":"40,941","price_per_share":18.497620722503115,"price_display":"18.50","price_state":"stated","total_value":757311.09,"total_display":"757,311.09","total_whole":"757,311","shares_owned_after":40766.0,"shares_owned_after_display":"40,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-05","scope":"insider","n_lines":2},{"id":6339107,"accession":"0001410939-22-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001410939-22-000046","line_url":"/filing/0001410939-22-000046#line-1","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2144.0,"shares_display":"2,144","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":36448.0,"total_display":"36,448.00","total_whole":"36,448","shares_owned_after":60791.0,"shares_owned_after_display":"60,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-05","scope":"insider"},{"id":6315104,"accession":"0001410939-22-000033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001410939-22-000033","line_url":"/filing/0001410939-22-000033#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16772.0,"shares_display":"16,772","price_per_share":17.0157,"price_display":"17.02","price_state":"stated","total_value":285387.3204,"total_display":"285,387.32","total_whole":"285,387","shares_owned_after":62935.0,"shares_owned_after_display":"62,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-25","filed_date":"2022-03-29","scope":"insider"},{"id":6129439,"accession":"0001410939-22-000024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001410939-22-000024","line_url":"/filing/0001410939-22-000024#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11561.0,"shares_display":"11,561","price_per_share":17.0022,"price_display":"17.00","price_state":"stated","total_value":196562.4342,"total_display":"196,562.43","total_whole":"196,562","shares_owned_after":62944.0,"shares_owned_after_display":"62,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-18","filed_date":"2022-03-22","scope":"insider"},{"id":6513097,"accession":"0001104659-22-000976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-000976","line_url":"/filing/0001104659-22-000976#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15819.0,"shares_display":"15,819","price_per_share":16.3923,"price_display":"16.39","price_state":"stated","total_value":259309.7937,"total_display":"259,309.79","total_whole":"259,310","shares_owned_after":65504.0,"shares_owned_after_display":"65,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-04","scope":"insider"},{"id":4769135,"accession":"0001104659-21-153088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-153088","line_url":"/filing/0001104659-21-153088#line-1","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56207.0,"shares_display":"56,207","price_per_share":15.9826,"price_display":"15.98","price_state":"stated","total_value":898333.9982,"total_display":"898,334.00","total_whole":"898,334","shares_owned_after":48823.0,"shares_owned_after_display":"48,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-21","filed_date":"2021-12-23","scope":"insider"},{"id":4366530,"accession":"0001104659-21-152294","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-152294","line_url":"/filing/0001104659-21-152294#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6710.0,"shares_display":"6,710","price_per_share":15.4435,"price_display":"15.44","price_state":"stated","total_value":103625.885,"total_display":"103,625.88","total_whole":"103,626","shares_owned_after":105030.0,"shares_owned_after_display":"105,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-21","scope":"insider"},{"id":4282909,"accession":"0001104659-21-149632","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-149632","line_url":"/filing/0001104659-21-149632#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5836.0,"shares_display":"5,836","price_per_share":14.7449,"price_display":"14.74","price_state":"stated","total_value":86051.2364,"total_display":"86,051.24","total_whole":"86,051","shares_owned_after":97365.0,"shares_owned_after_display":"97,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-14","scope":"insider"},{"id":4312898,"accession":"0001104659-21-149245","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-149245","line_url":"/filing/0001104659-21-149245#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3614.0,"shares_display":"3,614","price_per_share":14.5315,"price_display":"14.53","price_state":"stated","total_value":52516.841,"total_display":"52,516.84","total_whole":"52,517","shares_owned_after":90701.0,"shares_owned_after_display":"90,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-13","scope":"insider"},{"id":5369884,"accession":"0001104659-21-000894","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-000894","line_url":"/filing/0001104659-21-000894#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11875.0,"shares_display":"11,875","price_per_share":6.85,"price_display":"6.85","price_state":"stated","total_value":81343.75,"total_display":"81,343.75","total_whole":"81,344","shares_owned_after":80165.0,"shares_owned_after_display":"80,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":8053983,"accession":"0001104659-19-039283","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-039283","line_url":"/filing/0001104659-19-039283#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2773.0,"shares_display":"2,773","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":3466.25,"total_display":"3,466.25","total_whole":"3,466","shares_owned_after":13707.0,"shares_owned_after_display":"13,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-02","filed_date":"2019-07-03","scope":"insider"},{"id":6041353,"accession":"0001104659-18-043878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-043878","line_url":"/filing/0001104659-18-043878#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2736.0,"shares_display":"2,736","price_per_share":2.68,"price_display":"2.68","price_state":"stated","total_value":7332.48,"total_display":"7,332.48","total_whole":"7,332","shares_owned_after":8980.0,"shares_owned_after_display":"8,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-03","scope":"insider"},{"id":4363698,"accession":"0001104659-17-043660","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-043660","line_url":"/filing/0001104659-17-043660#line-2","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001703623","owner_name":"Carroll David Francis","owner_display_name":"Carroll David Francis","owner_url":"/insider/0001703623","role":"Officer (SVP, CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3284.0,"shares_display":"3,284","price_per_share":2.58,"price_display":"2.58","price_state":"stated","total_value":8472.72,"total_display":"8,472.72","total_whole":"8,473","shares_owned_after":4216.0,"shares_owned_after_display":"4,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001410939","name":"IVERIC bio, Inc.","url":"/issuer/0001410939","role":"Officer (SVP, Chief Financial Officer)","n_filings":17,"first_seen":"2017-07-05","last_seen":"2023-05-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001703623","retrieved_at":"2026-08-27T00:15:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}